Coherus BioSciences, Inc.
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Coherus BioSciences, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Coherus BioSciences, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Coherus BioSciences, Inc..